F 0602
Protect each resident from the wrongful use of the resident's belongings or money.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
medical record review and interview the facility failed to ensure narcotic medication was not
misappropriated. This affected one resident (#86) of three residents reviewed for pain management.
Findings include:Closed record review revealed Resident #86 was admitted to the facility on [DATE] with a
diagnoses including chronic pain syndrome, Parkinsonism, pain and stiffness in right and left shoulder,
osteoarthritis, carpal tunnel syndrome, hereditary and idiopathic neuropathy, thrombocytopenia, metabolic
encephalopathy, aphasia, and cerebral infarction. The resident was discharged to the hospice facility on
07/28/25. Review of Resident #86's significant change in status minimum data set (MDS) dated [DATE]
revealed the resident was absent of spoken words and sometimes understood. The resident had severe
cognition impairment and no behavioral symptoms. Resident #86 was on a scheduled pain medication
regimen and could not answer the pain assessment interview questions. The staff assessment pain section
was conducted and indicated the resident had non-verbal sounds and facial expression for indicators for
pain. The resident had indicators of pain or possible pain observed one to two days. The resident was
receiving hospice care. Review of Resident #86's plan of care dated 06/19/23 revealed the resident was at
risk for pain and/or has chronic pain related to neuropathy, cerebral infarction, shoulder replacement,
osteoarthritis, depression, left hip pain, bilateral lower extremities pain, and history of chronic pain.
Intervention included to offer non-pharmacological interventions, administer medication as ordered and
observe for ineffectiveness and side effects, report abnormal findings, anticipate the resident's need for
pain relief as needed and respond immediately to any complaint of pain, identify residents' existing
conditions which may increase pain and or discomfort (arthritis, neuropathy, osteoporosis) and provide
appropriate pain management treatments, notify physician if interventions are unsuccessful or if current
complaints was significant change from residents past experience of pain, observe and report any signs
and symptoms of non-verbal pain, vocalizations, mood/behaviors (more irritable, restless, aggressive,
squirmy, constant motion), eyes (tearing), body (tense, ridged, rocking, curled up, thrashing) and report
abnormal findings to the physician. Review of Resident #86's risk for discomfort or adverse side effects
from pain medication plan of care dated 01/25/25 revealed the resident was on pain medication therapy
(Oxycodone, Tylenol, Ibuprofen, and Gabapentin) for chronic shoulder pain. Intervention included
administering medication as orders and observe for altered mental status, anxiety, constipation,
depression, dizziness, lack of appetite, nausea, vomiting, pruritus, respiratory distress, sedation, urinary
retention, and notify physician if indicated. Review of Resident #86's risk for decline in condition, pain,
depression, weight loss and other symptom related to terminal prognosis dated 05/22/25 revealed the
resident was receiving hospice. Intervention included assess resident's coping strategies and respect the
residents wishes, consult hospice, encourage resident/family to express feelings, observe for adverse
reactions and symptoms of end of life such as nausea/vomiting, difficulty breathing, agitation, observe
resident closely for signs of
Residents Affected - Few
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 8
Event ID:
366363
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366363
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/05/2026
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Laurels of Steubenville The
500 Stanton Boulevard
Steubenville, OH 43952
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0602
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
pain, administer pain medications as ordered, and notify physician immediately if there was breakthrough
pain, refer to hospice plan of care, work cooperatively with hospice team, and work with nursing staff to
provide maximum comfort for the resident.a. Review of Resident #86's narcotic control sheet dated
05/22/25 revealed the facility had received 60 Oxycodone 5 milligram (mg) tablets on 05/23/25. The sheet
indicated there were 27 remaining on 06/09/25 and only one was disposed of on 06/23/25. Review of the
MAR dated 06/2025 revealed the resident had received Oxycodone 5 mg one tablet on 06/09/25 at 8:00
A.M. and 4:00 P.M., 06/10/25 at midnight, 8:00 A.M., and 6:00 P.M., 06/11/25 at midnight, 8:00 A.M., and
6:00 P.M., 06/12/25 at midnight at midnight, 8:00 A.M., noon, and 6:00 P.M., and two tablets on 06/13/25 at
midnight and 8:00 A.M., however there was no evidence of the narcotic control sheet for the 16 doses
administered from 06/09/25 to 06/13/25. A new card of Oxycodone 10 mg was received on 06/13/25 and
started on 06/13/25 at 4:39 P.M. Reconciliation of the narcotic control sheet and MAR revealed there should
have been 11 Oxycodone 5 mg remaining if the doses were administered per the MAR. Interview on
12/30/25 at 3:27 P.M., with the Administrator and Director of Nursing confirmed there was no narcotic
control sheet to account for the 27 Oxycodone 5 mg that remained on 06/09/25. The Administrator reported
the narcotic control sheet may have been double sided and the facility did not scan the other side of the
control sheet. b. Review of Resident #86's orders dated 05/30/25 to 06/17/25 revealed Resident #86 was
ordered Ativan 0.5 mg every six hours as needed for anxiety/restlessness. Reconciliation of the June 2025
MAR and narcotic control sheet for Ativan 0.5 mg revealed on 06/01/25 a narcotic was signed off the
narcotic control sheet at 1800 (6:00 P.M.), however was not documented on the MAR. On 06/07/25 the
narcotic control sheet indicated Ativan 0.5 mg was administered at 9:00 A.M. and 4:00 P.M., however was
never documented on the MAR. On 06/08/25 the narcotic control sheet indicated Ativan 0.5 mg was
administered at 2:00 P.M., however was never documented on the MAR. On 06/14/25 the narcotic control
sheet indicated Ativan 0.5 mg was administered at 12:20 P.M., however was never documented on the
MAR. Further review revealed the resident had refused Ativan 0.5 mg on 06/17/25 at 2:00 P.M., 06/17/25 at
10:00 P.M., and 06/18/25 at 6:00 P.M., the narcotics were signed off the narcotic control sheet, however no
evidence the medication was wasted. c. Review of Resident #86's orders dated 07/26/25 revealed Ativan
was changed to 1 mg every four hours scheduled and every hour as needed. Review of the narcotic control
sheet revealed two tablets were removed at 2:45 P.M. on 07/26/25, however it was not documented on the
MAR. Interview on 12/30/25 at 4:22 P.M., with the Administrator and DON reconciled Ativan with the
surveyor and confirmed the above findings during the reconciliation. d. Review of Resident #86's orders
dated 06/01/25 revealed Morphine Sulfate 0.25 milliliters (ml) every four hours as needed for pain. On
06/18/25 the order was changed to 0.5 ml every two hours as needed. Reconciliation of the June (2025)
MAR and narcotic control sheet dated 06/2025 revealed Morphine 0.25 ml was signed off the narcotic
control sheet on 05/15/25 at 10:30 A.M. and 2:30 P.M., 06/16/25 at 6:00 P.M., 06/22/25 at noon and 4:00
P.M., however not signed off on the MAR. Further review of the narcotic control sheet revealed on 07/24/25,
0.5 ml was removed at 8:00 A.M., 12:00 P.M., and 4:00 P.M., however not signed off by the nurse
administering. Review of the facility policy tilted Medication Administration dated 03/01/13 and revised
10/17/23 revealed to record the dose, route, and time of medication on the Medication/Treatment
Administration Record. Interview on 12/29/25 from 12:39 P.M. to 3:30 P.M. and 12/30/25 at 10:13 A.M., with
anonymous staff members #103, #107, and #111 confirmed Resident #86 daughter was upset due to one
nurse would not administer Resident #86's pain medication per hospice orders. Interview on 12/30/25 at
4:22 P.M., with the director of nursing (DON) and Administrator confirmed findings during reconciliation with
the surveyor. The DON confirmed the nurse did not sign off the Morphine on the control
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366363
If continuation sheet
Page 2 of 8
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366363
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/05/2026
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Laurels of Steubenville The
500 Stanton Boulevard
Steubenville, OH 43952
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0602
Level of Harm - Minimal harm
or potential for actual harm
sheets on 07/24/25. Interview on 12/30/25 at 10:00 A.M., with Resident #86's daughter confirmed her
mother did not receive pain medication as ordered by hospice. This deficiency represents non-compliance
investigated under Complaint Number 2614918.
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366363
If continuation sheet
Page 3 of 8
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366363
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/05/2026
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Laurels of Steubenville The
500 Stanton Boulevard
Steubenville, OH 43952
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0697
Provide safe, appropriate pain management for a resident who requires such services.
Level of Harm - Actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
closed medical record review, review of hospice records, review of a facility soft file, interview, and policy
review the facility failed to implement an effective pain management program, including the administration
of scheduled and as needed opioid medication to effectively manage Resident #86's pain.Actual Harm
occurred beginning on [DATE], when Resident #86, who was identified with chronic pain and a new onset
of end of life care for pain management, did not receive scheduled or as needed Oxycodone (narcotic pain
medication), resulting in uncontrolled pain affecting the resident's end of life care requiring increasing and
changing the residents pain medication to re-gain control of the resident's pain. This affected one resident
(#86) of three residents reviewed for pain.Findings include: Review of Resident #86's closed medical record
revealed the resident was admitted to the facility on [DATE] with diagnoses including chronic pain
syndrome, Parkinsonism, pain and stiffness in right and left shoulder, osteoarthritis, carpal tunnel
syndrome, hereditary and idiopathic neuropathy, thrombocytopenia, metabolic encephalopathy, aphasia,
and cerebral infarction. The resident was discharged to a hospice facility on [DATE].Review of Resident
#86's plan of care dated [DATE] revealed the resident was at risk for pain and/or had chronic pain related to
neuropathy, cerebral infarction, shoulder replacement, osteoarthritis, depression, left hip pain, bilateral
lower extremities pain, and history of chronic pain. Interventions included to offer non-pharmacological
interventions, administer medication as ordered and observe for ineffectiveness and side effects, report
abnormal findings, anticipate the residents need for pain relief as needed and respond immediately to any
complaint of pain, identify residents' existing conditions which may increase pain and or discomfort
(arthritis, neuropathy, osteoporosis) and provide appropriate pain management treatments, notify physician
if interventions are unsuccessful or if current complaints was significant change from residents past
experience of pain, observe and report any signs and symptoms of non-verbal pain, vocalizations,
mood/behaviors (more irritable, restless, aggressive, squirmy, constant motion), eyes (tearing), body (tense,
ridged, rocking, curled up, thrashing) and report abnormal findings to the physician.Review of Resident
#86's risk for discomfort or adverse side effects from pain medication plan of care dated [DATE] revealed
the resident was on pain medication therapy (Oxycodone, Tylenol, Ibuprofen, and Gabapentin) for chronic
shoulder pain. Interventions included administering medication as ordered and observe for altered mental
status, anxiety, constipation, depression, dizziness, lack of appetite, nausea, vomiting, pruritis, respiratory
distress, sedation, urinary retention, and notify physician if indicated.Review of Resident #86's risk for
decline in condition, pain, depression, weight loss and other symptom related to terminal prognosis dated
[DATE] revealed the resident was receiving hospice services. Intervention included assess resident's
coping strategies and respect the residents wishes, consult hospice, encourage resident/family to express
feelings, observe for adverse reactions and symptoms of end of life such as nausea/vomiting, difficulty
breathing, agitation, observe resident closely for signs of pain, administer pain medications as ordered, and
notify physician immediately if there was breakthrough pain, refer to hospice plan of care, work
cooperatively with hospice team, and work with nursing staff to provide maximum comfort for the
resident.Review of Resident #86's nursing progress notes revealed on [DATE] the resident had increased
drowsiness, trouble with fine motor skills, and decreased appetite. Cymbalta had been increased to 60
milligrams (mg) twice daily on [DATE]. New orders to hold Cymbalta for 24 hours and restart 20 mg for two
days, then start 30 mg daily was provided at this time. Review of Resident #86's nursing progress note
dated [DATE] revealed the resident's daughter was aware of the resident's acute functional decline and
wished to have hospice consulted. Hospice
Residents Affected - Few
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366363
If continuation sheet
Page 4 of 8
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366363
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/05/2026
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Laurels of Steubenville The
500 Stanton Boulevard
Steubenville, OH 43952
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0697
Level of Harm - Actual harm
Residents Affected - Few
in facility and consulted with daughter and daughter has decided to move forward and sign
paperwork.Review of Resident #86's hospice agreement and note dated [DATE] revealed the resident's
prior pain medication regime included Lidocaine patch four percent apply for 12 hours and remove for 12
hours daily for pain, Gabapentin 300 mg twice daily for neuropathy, Ibuprofen 400 mg twice daily for pain,
Oxycodone 5 mg twice daily for pain, and Tylenol Extra Strength 500 mg two tablets three times daily. The
resident's daughter had reported the resident had knee replacement and surgery on both shoulders and
had been in constant pain and was taking Oxycodone, Tylenol, and ibuprofen scheduled. Resident
grimaced any time she moves, above medications were not effective. Hospice recommended to increase
Oxycodone to every eight hours and as needed. Message left with provider for approval. Review of
Resident #86's hospice psychosocial admission assessment dated [DATE] revealed the resident was
asleep when the social worker arrived. The resident arose easily, her speech was mumbled and she was
confused and unable to answer questions appropriately. The facility nurse reported the resident had been
sleeping most of the day.Review of Resident #86 hospice note date [DATE] revealed hospice had met with
Resident #86's daughter. The resident was alert sitting up in bed and attempted to communicate but
speech was garbled, but did shake head yes and no. The daughter was grateful for support and wanted
comfort for the resident. The physician approved the Oxycodone recommendation; the daughter agreed
with the medication changes and the facility nurse was updated and voiced no concerns. The resident's
prescription was sent to the pharmacy.Review of Resident #86's hospice physician order dated [DATE]
revealed new orders for Oxycodone 5 mg every eight-hour scheduled, and every four hours as needed for
pain and Zofran 4 mg every six hours as needed for nausea and vomiting. An order was also provided to
discontinue the Oxycodone 5 mg twice daily. Review of the Oxycodone control sheet dated [DATE] and
received on [DATE] revealed Oxycodone 5 mg every eight hours scheduled, and every four hours as
needed.Review of Resident #86's medical record revealed no evidence the new orders to change the
Oxycodone 5 mg to every eight hours scheduled and every four as needed and Zofran 4 mg every six
hours as needed was implemented on [DATE]. The orders were not implemented until [DATE] at 7:43 P.M.
(three days after medication was ordered).Review of Resident #86's hospice note dated [DATE] revealed
the resident was alert and pleasant but speech was garbled. The resident had a fall yesterday which
resulted in no injuries. The resident could not respond to pain questions; however, breathing was normal, no
facial expressions of pain, and body was relaxed. Review of Resident #86's medication administration
records (MAR) dated 05/2025 revealed the resident did not receive the scheduled Oxycodone 5 mg at
10:00 P.M. on [DATE] or the 6:00 A.M. dose on [DATE] because she was sleeping. The narcotic control
sheet dated [DATE] revealed the Oxycodone 5 mg was signed out on [DATE] at 10:00 P.M. with no evidence
the medication was wasted. In addition, there was no evidence the resident had received the Oxycodone as
needed from [DATE] to [DATE].Review of Resident #86 significant change in status Minimum Data Set
(MDS) assessment dated [DATE] revealed the resident was absent of spoken words and sometimes
understood. The resident had severe cognition impairment and no behavioral symptoms. The assessment
revealed Resident #86 was on a scheduled pain medication regimen and could not answer the pain
assessment interview questions. The staff assessment pain section was conducted and indicated the
resident had non-verbal sounds and facial expression for indicators for pain. The resident had indicators of
pain or possible pain observed one to two days. The resident was receiving hospice care. Review of
Resident #86's hospice note dated [DATE] revealed the resident had been anxious since this morning.
Daughter pushes the resident in her wheelchair. The resident shook head yes she was having pain. The
resident was tearful during visit and fidgeting. New orders received for Ativan 0.5 mg four times daily as
needed and Oxycodone increased to 10 mg every six hours and discontinue 5 mg
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366363
If continuation sheet
Page 5 of 8
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366363
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/05/2026
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Laurels of Steubenville The
500 Stanton Boulevard
Steubenville, OH 43952
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0697
Level of Harm - Actual harm
Residents Affected - Few
every eight hours scheduled, and every four hours as needed.Review of Resident #86 narcotic control
sheet and MAR dated 05/2025 revealed the Resident received the scheduled Oxycodone 5 mg on [DATE]
at 2:00 P.M. per the MAR, however there was no evidence the Oxycodone 5 mg was signed off the narcotic
control sheet. The MAR indicated the Oxycodone 5 mg scheduled and the as needed orders were
discontinued on [DATE] at 7:43 P.M. There was no evidence that the resident had received Oxycodone 5
mg or 10 mg on [DATE] (as evidenced by the Oxycodone not being signed off on the narcotic control
sheet). Review of Resident #86's orders and MAR dated [DATE] revealed the resident did not receive the
Oxycodone 10 mg at midnight on [DATE] because she was sleeping.Review of Resident #86's progress
notes dated [DATE] at 11:08 A.M. revealed the resident's daughter had spoken to this nurse regarding the
resident's new hospice orders. Upon chart review it was discovered that the resident was historically on
Oxycodone 5 mg twice daily, while reviewing the chart this nurse noted the scheduled 2:00 A.M., dose was
not administered on more than one occasion with charting code sleeping. Residents' pain was well
controlled with this regimen when all doses were administered. The resident's daughter was made aware of
missed doses and changes in pain management routine that resulted in the resident's increased pain that
hospice had noted upon assessment. At this time the resident's daughter wished to resume original order
of 5 mg Oxycodone at 2:00 A.M. and 4:00 P.M. Hospice nurse made aware of the above. Physician aware
of the above and agreeable to resume historical order. Review of a clarification note dated [DATE] at 11:28
A.M., revealed Oxycodone was historically scheduled at 6:00 A.M., 2:00 P.M., and 10:00 P.M., and every
four hours as needed. Review of Resident #86's progress note dated [DATE] revealed the resident's
daughter was very teary eyed. The daughter stated she spoke with her mom after yesterday's fall, and the
resident and family wanted to start hospice end of life drugs. She (the resident) doesn't want to be in pain
and suffer any longer.Review of Resident #86's hospice physician orders dated [DATE] revealed new orders
for Morphine concentrated solution 20 mg/milliliter (ml) give 0.25 ml every four hours as needed for
pain/dyspnea. There was no documented evidence to discontinue the Oxycodone 5 mg scheduled or as
needed.Review of progress note dated [DATE] revealed the nurse documented the physician reviewed
medication and discontinued some medications. Keep Oxycodone until morphine starts and then
discontinue. The note didn't indicate which Oxycodone order to discontinue the scheduled or as
needed.Review of Resident #86's Morphine (narcotic) control sheet revealed the Morphine was received on
[DATE] and the first as needed dose was administered on [DATE] at 4:30 P.M.Review of Resident #86's
orders revealed on [DATE] at 9:34 P.M., the three times a day scheduled and the as needed Oxycodone
orders were both discontinued.Review of the hospice note dated [DATE] revealed the resident was sitting
up in wheelchair, pleasant, and no signs or symptoms of distress. The daughter was tearful as it was a
rough weekend. The unit manager had called the physician to ask if the new pain medication order was not
being started as a medication dose was missing at 2:00 A.M. The resident was agitated Saturday ([DATE])
and had a fall Saturday afternoon and was transported to the hospital with a hematoma to the top of the
head. The CT was negative. The resident's daughter stated the resident was in pain on Sunday and
frustrated as the resident was suffering. New orders were obtained from hospice for Morphine 5 mg as
needed every four hours. Education was provided on use of as needed Ativan for increased anxiety to
nurse (Registered Nurse (RN) #113). After medical record review with RN #113 the previous Oxycodone 5
mg order (from [DATE]) was not placed in the resident orders and the resident had not received it. The
previous Oxycodone 5 mg order every 8 hours scheduled was added. The resident's daughter was at the
beside aware and grateful.Review of a progress note dated [DATE] revealed the hospice nurse was present
and had ordered this nurse to restart the Oxycodone 5 mg every eight hours as scheduled. Review of a
progress note dated [DATE] revealed
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366363
If continuation sheet
Page 6 of 8
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366363
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/05/2026
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Laurels of Steubenville The
500 Stanton Boulevard
Steubenville, OH 43952
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0697
Level of Harm - Actual harm
Residents Affected - Few
the resident's daughter had concerns the resident was having uncontrolled pain. Hospice updated and
requested we give the Morphine every four hours and keep the as needed and monitor.Review of a hospice
note dated [DATE] revealed the facility had changed the resident's pharmacy. There was a new order for
Oxycodone 10 mg three times daily. Resident #86‘s daughter reported that the resident was doing
wonderful, does not want to change pain regimen at this time. Further review of Oxycodone narcotic control
sheets and MAR dated 06/2025 revealed the MAR indicated Oxycodone 10 mg was administered at 8:00
A.M., on [DATE], [DATE] at midnight, 8:00 A.M., and 6:00 P.M., and [DATE] at 8:00 A.M., however the
medication was not signed off on the narcotic control sheets. The control sheet indicated 20 pills were
received on [DATE] of Oxycodone 10 mg. On tablet was removed on [DATE] at 4:39 P.M., one tablet on
[DATE] at midnight and 11:30 P.M., no tablets were removed on [DATE], one on [DATE] at midnight and
4:00 P.M. and [DATE] at midnight. The remaining 14 tablets were destroyed on [DATE].Review of a progress
note dated [DATE] revealed the resident was displaying increased signs of anxiety during medication
administration, including physically grasping at this nurse's arm. Hospice contacted about increased
agitation. Hospice stated they would be in today to assess resident.Review of hospice note dated [DATE]
revealed the resident pain was assessed by non-verbal. The resident was tense, distressed, rubbing legs,
fidgeting and refusing medication. The resident was yelling, smacking and kicking. New orders for Fentanyl
patch and discontinue the scheduled Morphine order. Review of a hospice note dated [DATE] revealed the
Director of Nursing (DON) called asking for Morphine to be scheduled as some facility nurses do not
administer. The resident was exhibiting signs of pain. The nurse had reported prior to hospice arriving the
resident was crying, moaning; morphine was administered prior to hospice arriving. Nurse reported the
resident receives Morphine every four hours, she experiences good effects. Physician updated and
Morphine scheduled every four hours. Review of the facility's soft file for Resident #86 revealed a guest
satisfaction concern form dated [DATE] indicating Resident #86 daughter called the DON down to 200 hall
Unit Mangers office to voice concerns the resident's pain medication was not being administered when the
resident was sleeping. She stated she wanted the resident to be woken up and given pain medication
regardless. The daughter voiced a concern that RN #113 wasn't giving medication when her mom was
sleeping. The investigation indicated the MAR was reviewed and medications were given as ordered.
Hospice notified of daughter's concerns. The Administrator had an unsigned typed letter dated [DATE] at
the top that indicated Resident #86's daughter didn't feel her mom was medicated properly. The daughter
had a time of events, however never told the DON because the Unit Manager told her that they wouldn't get
addressed. The daughter felt staff could benefit from Hospice training and the Administrator agreed and set
up empathy training for staff with Hospice. Included in the soft file was an email from the [NAME] President
of Operations dated [DATE] that himself and Division Director of Clinical Service reviewed the medical
record (of Resident #86). It was his understanding the that the Ohio Department of Health had been into
the facility to investigate the same concerns. Information contained in the soft file revealed the [NAME]
President of Operations indicated that appropriate actions had been taken with the facility staff to address
(family) concerns and provide education as necessary.The soft file included staff education on hospice
services on [DATE] and all staff meeting in June (2025) that included notifying hospice of change of
condition and when to administer as needed medication. Review of the facility policy titled Pain
Management dated [DATE] and revised [DATE] revealed the facility would evaluate and identify residents'
pain, determine the type, location, severity, and develop a care plan for pain management. If a resident who
has dementia and cannot verbalize that they are feeling pain, symptoms of pain can be manifested by
particular behavior such as calling out of help, facial expression, refusing
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366363
If continuation sheet
Page 7 of 8
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366363
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/05/2026
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Laurels of Steubenville The
500 Stanton Boulevard
Steubenville, OH 43952
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0697
Level of Harm - Actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
to eat, striking out when moved or touched, and increased confusion.Interview on [DATE] from 12:39 P.M.
to 3:30 P.M. and [DATE] at 10:13 A.M., with anonymous staff members #103, #107, and #111 confirmed
Resident #86's daughter was upset due to a facility nurse not administering Resident #86 medication per
hospice orders. The nurse didn't believe in hospice.Interview on [DATE] at 3:19 P.M., with the Administrator
revealed Resident #86's daughter had voiced concerns to the corporate office, and they completed an
investigation and had no negative findings related to the daughters' concerns. The daughter had voiced
concerns to the Unit Manager; however, the Unit Manager did not forward the concerns to the DON or
herself. The Unit Manager was no longer employed by the facility. The Administrator reported the DON was
not aware of the family's concerns until the end of July (2025) after the resident had expired. Resident #86
had gone to the hospice house around [DATE] and expired a few days later. The Administrator reported she
would have to see if the DON completed a concern form. Interview on [DATE] at 10:00 A.M., with Resident
#86's daughter revealed in [DATE] she had consulted Hospice for pain management for her mother. There
was one nurse who would refuse to medicate her mother per hospice orders and plan of care. She (the
daughter) visited her mother daily. Her mom was not able to speak but showed non-verbal cues of pain.
When she (the daughter) would request pain medication the nurse would say She doesn't need it or She
has been fine and been sleeping. The nurse told hospice once she didn't agree with their orders. On
[DATE]th (2025) the daughter had spoken to the DON and was assured staff would be educated on pain
management and as needed orders including the nurse that refused to medicate her mother. (See above
hospice note dated [DATE] that the DON called hospice requesting scheduling Morphine due some facility
nurses don't administer medication). Resident #86's daughter reported she could not continue to arrive for
routine visit daily to find her mother in severe pain and distress. She moved her mom to the hospice house
where she had expired a few days later. Interview on [DATE] at 3:27 P.M., with the DON and Administrator
confirmed the hospice order on [DATE] to increase the Oxycodone 5 mg to every eight hours schedule and
every four hours as needed, and Zofran was not implemented until [DATE] because the facility was not
aware of the new orders on [DATE]. The Administrator reported the facility had changed pharmacies on
[DATE] and she would have to call the previous pharmacy for records. The Administrator received a
printout; the records were not legible, however the narcotic control sheet indicated the new order was
received by the facility on [DATE]. The DON confirmed Resident #86 did not receive scheduled Oxycodone
on [DATE] at 10:00 P.M. and [DATE] at 6:00 A.M., per the MAR because the resident was sleeping. The
DON reported nurses use their assessment skills to determine if it was safe to administer medications. The
DON confirmed there was some confusion regarding the Oxycodone and Morphine order that was received
on [DATE], however the hospice nurse clarified on [DATE] the scheduled Oxycodone should have been
given resulting in the resident missing two doses of Oxycodone the morning of [DATE]. The DON confirmed
there were no narcotic control sheets to prove the resident had received Oxycodone 10 mg on 8:00 A.M.,
on [DATE], [DATE] at midnight, 8:00 A.M., and 6:00 P.M., and [DATE] at 8:00 A.M. per the MAR. The
medication was not removed from the emergency contingency machine either per the DON. Another
resident had concerns on [DATE] that pain medication was not provided upon request timely. This residents'
concerns were not identified as part of the facility's investigation. This deficiency represents
non-compliance investigated under Complaint Number 2614918.
Event ID:
Facility ID:
366363
If continuation sheet
Page 8 of 8